JamesWmKupiecMD

Internal Medicine • Austin, TX

Chief Clinical Development Officer, Cassava Sciences, Inc.

Join to view full profile

Dr. Kupiec is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kupiec's full profile

Already have an account?

Office
7801 N Capital of Texas Highway
Suite 260
Austin, TX 78731
Phone+1 860-514-6900
Is this information wrong?

Education & Training

University of RochesterResidency, Internal Medicine, 1978 - 1981
Albert Einstein College of MedicineClass of 1978

Certifications & Licensure

PA State Medical License 1994 - 2020
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

123 citations
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko, Joanne Bell, Jessica Mancuso, James W. Kupiec, Marwan N. Sabbagh
Neurology. 2014-04-29
36 citations
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to mod...
Marielle Delnomdedieu, Sridhar Duvvuri, David Li, Nazem Atassi, Ming Lu
Alzheimer's Research & Therapy. 2016-03-01
18 citations
Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, ...
Izuru Miyoshi, Yoko Fujimoto, Masahito Yamada, Sadahiro Abe, Qinying Zhao
International Journal of Clinical Pharmacology and Therapeutics. 2013-12-01

Press Mentions

Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s DiseaseFebruary 8th, 2023
Alkermes Promotes from Within to Find New CFO and COO in Rebound Effort; Moderna Vet Robert Dolski Joins Checkmate as CFOJanuary 8th, 2021
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development OfficerJanuary 4th, 2021
Join now to see all